Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study.
Zhang Y, Yuan Z, Zhang GN, Li QS, Cui MH, Cheng WJ, Meng YG, Wu XH, Yue Y, Wang L, Hou JQ, Li CZ, Qu PP, Sun LX, Tao GS, Li GL, Chen YQ, Ren F, Cao DY, Shen K.
Zhang Y, et al. Among authors: li cz.
Oncologist. 2024 Nov 4:oyae194. doi: 10.1093/oncolo/oyae194. Online ahead of print.
Oncologist. 2024.
PMID: 39494888